
Etograb 600mg Tablet ER
Marketer
Medxone Healthcare
Salt Composition
Etodolac (600mg)
Overview Etograb 600mg Tablet ER
Arthrolief 600mg Extended-Release Tablets provide effective pain and inflammation relief. This medication is indicated for conditions such as rheumatoid arthritis, osteoarthritis, and acute pain episodes. Dosage and treatment duration should strictly adhere to your physician's instructions. Administering the tablet with food or milk minimizes potential gastrointestinal discomfort. Prior heart disease or stroke should be disclosed to your doctor before commencing treatment. Commonly reported side effects include nausea, vomiting, indigestion, and abdominal pain. Dizziness, somnolence, or visual abnormalities may also occur. For prolonged therapy, regular monitoring of kidney function, liver function, and blood counts is typically recommended by your healthcare provider. Protracted use carries the risk of serious complications, including peptic ulcers and renal impairment.
Primary Ingredients of Etograb 600mg Tablet ER
No text was provided to rewrite.
Uses of Etograb 600mg Tablet ER
Analgesia
Major Benefits of Etograb 600mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet; avoid chewing, crushing, or breaking it. Etograb 600mg Extended-Release Tablets should be administered with a meal.
Common Side effects of Etograb 600mg Tablet ER:
- Vomiting
- Stomach pain/epigastric pain
- Nausea
- Indigestion
- Dizziness
- Drowsiness
How to use Etograb 600mg Tablet ER:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Administer Etograb 600mg Extended-Release Tablet with a meal.
How Etograb 600mg Tablet ER works:
Etograb 600mg Extended-Release tablets are a non-steroidal anti-inflammatory drug (NSAID) that inhibits the production of inflammatory mediators responsible for pain and associated inflammation, such as redness and edema.
SAFETY ADVICE
AlcoholUNSAFE
Combining Etograb 600mg Extended-Release Tablets with alcohol is dangerous.
PregnancyCONSULT YOUR DOCTOR
Extended-release Etograb 600mg tablets might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Etograb 600mg tablets are likely unsuitable for breastfeeding mothers. Available human data indicate potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking Etograb 600mg Extended-Release tablets might reduce attentiveness, impair vision, and cause drowsiness or dizziness. Refrain from driving if you experience these effects.
KidneySAFE IF PRESCRIBED
The extended-release Etograb 600mg tablet is likely safe for individuals with impaired kidney function. Available evidence indicates dose modification may not be necessary; however, physician consultation is recommended. Routine monitoring of kidney function is advised during treatment.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the use of Etograb 600mg extended-release tablets in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Etograb 600mg Tablet ER :
Should you forget a dose of Etograb 600mg Extended-Release Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Etograb 600mg Tablet ER
| Label | Value |
|---|---|
| Chemical Type | Indole Carboxylic Acid Derivatives |
| Developing Habits | No. |
| Type of Therapy | Pain Relievers |
